v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 15 $ 93
General and administrative 1,640 1,870
Loss from operations (1,655) (1,963)
Other income :    
Interest income 49 77
Change in fair value of warrant liability 0 294
Net loss (1,606) (1,592)
Net loss attributable to common stockholders, basic (726) (720)
Net loss attributable to common stockholders, diluted $ (726) $ (720)
Weighted-average shares of common stock outstanding, basic 98,503,430 98,503,430
Weighted-average shares of common stock outstanding, diluted 98,503,430 98,503,430
Net loss per share of common stock, basic $ (0.01) $ (0.01)
Net loss per share of common stock, diluted $ (0.01) $ (0.01)
Series B Redeemable Convertible Preferred Stockholders [Member]    
Other income :    
Net loss attributable to common stockholders, basic $ (880) $ (872)
Net loss attributable to common stockholders, diluted $ (880) $ (872)
Series B Redeemable Convertible Preferred Stock [Member]    
Other income :    
Weighted-average shares of common stock outstanding, basic 119,318 119,318
Weighted-average shares of common stock outstanding, diluted 119,318 119,318
Net loss per share of common stock, basic $ (7.37) $ (7.31)
Net loss per share of common stock, diluted $ (7.37) $ (7.31)